文献速递腹部MR

超顺磁性氧化铁增强扩散加权磁共振成像诊断胰腺内副脾

Superparamagnetic iron-oxide-enhanced diffusion-weighted magnetic resonance imaging for the diagnosis of intrapancreatic accessory spleen.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

本研究回顾性分析26例胰腺内副脾和9例胰尾肿瘤(神经内分泌肿瘤8例、胰腺腺癌1例),由两名盲法阅片者评估SPIO增强MRI。SPIO增强DWI的病灶可见度最高(2.8±0.3),鉴别SPIO摄取有无的正确率为97.1%,AUC达0.974和0.989,优于SPIO增强T2*WI和T2WI。

要点

  • SPIO增强DWI诊断胰腺内副脾的AUC为0.974和0.989,正确鉴别SPIO摄取有无的病例为34/35(97.1%)。
  • DWI病灶可见度评分为2.8±0.3,高于T2WI的2.3±0.7(p<0.001)和T2*WI的2.1±0.7(p<0.0001)。
  • DWI的AUC在阅片者2中显著高于T2WI(0.846,p<0.05)和T2*WI(0.803,p<0.01),在阅片者1中显著高于T2*WI(0.756,p<0.01)。

核心结论

  • SPIO增强DWI对胰腺内副脾的诊断效能优于SPIO增强T2*WI和T2WI。

研究设计与样本

  • 回顾性分析26例胰腺内副脾和9例胰尾肿瘤(神经内分泌肿瘤8例、胰腺腺癌1例),由两名盲法阅片者评估SPIO增强MRI。

关键影像表现/征象

  • 病灶可见度评分DWI为2.8±0.3,T2WI为2.3±0.7,T2*WI为2.1±0.7。
  • DWI上正确判断SPIO摄取有无的病例为34/35(97.1%),T2WI为24例(68.6%)和25例(71.4%),T2*WI为16例(45.7%)和17例(48.6%)。

诊断标准与关键数值

  • DWI的AUC在阅片者1为0.974,阅片者2为0.989。
  • T2WI的AUC在阅片者1为0.868,阅片者2为0.846;T2*WI的AUC在阅片者1为0.756,阅片者2为0.803。
  • 阅片者1的DWI AUC显著高于T2*WI(0.756,p<0.01),与T2WI(0.868)无显著差异(p=0.0857)。
  • 阅片者2的DWI AUC显著高于T2WI(0.846,p<0.05)和T2*WI(0.803,p<0.01)。

临床应用与阅片要点

  • SPIO增强DWI可用于区分胰腺内副脾与胰腺肿瘤,通过判断病灶有无SPIO摄取辅助诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the diagnostic performance of superparamagnetic iron-oxide (SPIO)-enhanced diffusion-weighted image (DWI) for distinguishing an intrapancreatic accessory spleen from pancreatic tumors.

MATERIALS AND METHODS: Twenty-six cases of intrapancreatic accessory spleen and nine cases of pancreatic tail tumors [neuroendocrine tumor (n = 8) and pancreatic adenocarcinoma (n = 1)] were analyzed. Two blind reviewers retrospectively reviewed the SPIO-enhanced magnetic resonance imaging (MRI) scans. The lesion visibility grades were compared and the diagnostic performance of SPIO-enhanced DWI was compared to those of SPIO-enhanced T2WI and T2*WI with the use of a receiver operating characteristic (ROC) analysis.

RESULTS: The grade of lesion visibility was the highest on DWI [mean ± standard deviation (SD): 2.8 ± 0.3] followed by T2WI (2.3 ± 0.7, p < 0.001) and T2*WI (2.1 ± 0.7, p < 0.0001). Reviewers 1 and 2 correctly characterized the presence or absence of SPIO uptake in 34 of 35 cases (97.1%) on DWI, 24 (68.6%) and 25 (71.4%) cases on T2WI, respectively, and 16 (45.7%) and 17 (48.6%) cases on T2*WI. The area under the ROC curve (AUC) of DWI was 0.974 and 0.989 for reviewers 1 and 2, respectively. For Reviewer 1, the AUC of DWI was significantly higher than that of T2*WI (0.756, p < 0.01), although it was not significantly different from that of T2WI (0.868, p = 0.0857). For Reviewer 2, the AUC of DWI was significantly higher than those of T2WI (0.846, p < 0.05) and T2*WI (0.803, p < 0.01).

CONCLUSION: The diagnostic performance of SPIO-enhanced DWI was better than those of SPIO-enhanced T2*WI and T2WI for the diagnosis of intrapancreatic accessory spleen.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Ishigami K, Nishie A, Nakayama T, et al. Superparamagnetic iron-oxide-enhanced diffusion-weighted magnetic resonance imaging for the diagnosis of intrapancreatic accessory spleen. Abdom Radiol (NY). 2019. PMID: 31420705. doi:10.1007/s00261-019-02189-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。